Vandana Singh
·
March 7, 2025
Benzinga
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
read more
March 9, 2025
January 13, 2025
Bloomberg
January 6, 2025
March 5, 2025